Back to search
FDAFDA · Food and drugs·Recall number D-0556-2024

Eptifibatide injection 20mg/10mL (2mg/mL), 10mL Single-Dose Vial, Rx only, Mfd. In India for: AuroMedics Pharma, LLC, E. Windsor, NJ 08520, NDC 55150-219-10

Published June 26, 2024 · Recall initiated: May 22, 2024

Summary

FDA records drug Class III recall D-0556-2024, published June 26, 2024 and initiated May 22, 2024. Recalling firm: Eugia US LLC; Status: Ongoing; Reported quantity: 15,500 single dose vials; Lot: Lot #: 3EF22003, Exp 6/30/2025. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.

What to do

Voluntary: Firm initiated · Letter

Get an email if EPTIFIBATIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
EPTIFIBATIDE
Manufacturer
Eugia US LLC
Distributor
USA nationwide.
UPC
0355150220991
Lot
Lot #: 3EF22003, Exp 6/30/2025
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Eptifibatide injection 20mg/10mL (2mg/mL), 10mL Single-Dose Vial, Rx only, Mfd. In India for: AuroMedics Pharma, LLC, E. Windsor, NJ 08520, NDC 55150-219-10 recalled?

Yes. FDA published recall D-0556-2024 on June 26, 2024. Reported hazard: Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: EPTIFIBATIDE. UPC: 0355150220991.